Akeso lung cancer drug shines in trials, boosting hopes in US$20b market
AdvertisementChina’s private sectorBusinessChina Business Akeso lung cancer drug shines in trials, boosting hopes in US$20b market Ivonescimab phase three trials…
Your Compass for Current News
AdvertisementChina’s private sectorBusinessChina Business Akeso lung cancer drug shines in trials, boosting hopes in US$20b market Ivonescimab phase three trials…
AdvertisementScienceChinaScience This compact Chinese device can detect cancer biomarkers in a drop of blood The new system is about 10,000…